We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$297B
AUM Growth
+$53.1B
Cap. Flow
+$26.9B
Cap. Flow %
9.06%
Top 10 Hldgs %
35.93%
Holding
10,215
New
1,302
Increased
3,894
Reduced
3,315
Closed
1,631

Sector Composition

Rank Sector Weight
1 Technology 3.96%
2 Consumer Discretionary 3.1%
3 Financials 1.5%
4 Healthcare 1.15%
5 Communication Services 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
8201
Lineage Cell Therapeutics
LCTX
$282M
$33K ﹤0.01%
23,420
-573,024
-96% -$792K
BKKT icon
8202
CALL
Bakkt Inc
BKKT
$318M
$33K ﹤0.01%
1,072
-288
-21% -$10.1K
SCYX icon
8203
SCYNEXIS
SCYX
$51.6M
$32.8K ﹤0.01%
1,391
-282
-17% -$6.59K
ME
8204
PUT
DELISTED
23andMe Holding Co
ME
$32.5K ﹤0.01%
930
-535
-37% -$21.3K
PRTK
8205
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$32.4K ﹤0.01%
14,668
-24,850
-63% -$51.5K
SPRU icon
8206
Spruce Power Holding Corp
SPRU
$42.2M
$32.1K ﹤0.01%
4,950
-7,791
-61% -$48.7K
BAERW icon
8207
Bridger Aerospace Warrant
BAERW
$10.9M
$32.1K ﹤0.01%
158,425
-522
-0.3% -$103
OPT
8208
DELISTED
Opthea Limited American Depositary Shares
OPT
$32K ﹤0.01%
+10,932
New +$37.4K
GOEV
8209
PUT
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$32K ﹤0.01%
+145
New +$41.4K
BXRX
8210
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$32K ﹤0.01%
+27,342
New +$26.1K
CLOV icon
8211
CALL
Clover Health Investments
CLOV
$2.45B
$31.6K ﹤0.01%
35,200
-38,400
-52% -$34.1K
AMWL icon
8212
American Well
AMWL
$220M
$31.4K ﹤0.01%
748
-547
-42% -$24.1K
PLM
8213
DELISTED
PolyMet Mining Corp.
PLM
$31.4K ﹤0.01%
+39,729
New +$59.6K
PAYS icon
8214
Paysign
PAYS
$693M
$31.3K ﹤0.01%
12,785
-152,837
-92% -$470K
VLD.WS
8215
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$30.9K ﹤0.01%
93,750
-1,122
-1% -$318
GROY icon
8216
Gold Royalty Corp
GROY
$662M
$30.2K ﹤0.01%
17,062
+6,695
+65% +$13.8K
RLMD icon
8217
Relmada Therapeutics
RLMD
$564M
$29.8K ﹤0.01%
+12,118
New +$33.5K
PLUR icon
8218
Pluri
PLUR
$19.5M
$29.7K ﹤0.01%
4,627
-3,446
-43% -$24.4K
WAVE
8219
Eco Wave Power Global
WAVE
$43.4M
$29.4K ﹤0.01%
+11,779
New +$32.6K
EVGN icon
8220
Evogene
EVGN
$8.29M
$29.4K ﹤0.01%
+2,747
New +$18.6K
KPTI icon
8221
PUT
Karyopharm Therapeutics
KPTI
$44.2M
$29.4K ﹤0.01%
1,093
+333
+44% +$14.3K
AZRE
8222
DELISTED
Azure Power Global Limited
AZRE
$28.7K ﹤0.01%
16,226
-52,968
-77% -$116K
AKA icon
8223
a.k.a. Brands
AKA
$118M
$28.6K ﹤0.01%
+5,551
New +$27.1K
NOTE.WS
8224
DELISTED
FiscalNote Holdings Warrants
NOTE.WS
$27.7K ﹤0.01%
62,500
-2,121
-3% -$499
LVO icon
8225
LiveOne
LVO
$56.9M
$27.6K ﹤0.01%
1,568
-1,730
-52% -$24.4K

Similar funds

Jane Street's Q2 2023 Portfolio in Review

As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.

By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.

  • Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
  • Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
  • Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
  • Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
  • Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
  • Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
  • Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.